Argenziano, M.; Gigliotti, C.L.; Clemente, N.; Boggio, E.; Ferrara, B.; Trotta, F.; Pizzimenti, S.; Barrera, G.; Boldorini, R.; Bessone, F.;
et al. Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models. Cancers 2020, 12, 162.
https://doi.org/10.3390/cancers12010162
AMA Style
Argenziano M, Gigliotti CL, Clemente N, Boggio E, Ferrara B, Trotta F, Pizzimenti S, Barrera G, Boldorini R, Bessone F,
et al. Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models. Cancers. 2020; 12(1):162.
https://doi.org/10.3390/cancers12010162
Chicago/Turabian Style
Argenziano, Monica, Casimiro Luca Gigliotti, Nausicaa Clemente, Elena Boggio, Benedetta Ferrara, Francesco Trotta, Stefania Pizzimenti, Giuseppina Barrera, Renzo Boldorini, Federica Bessone,
and et al. 2020. "Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models" Cancers 12, no. 1: 162.
https://doi.org/10.3390/cancers12010162
APA Style
Argenziano, M., Gigliotti, C. L., Clemente, N., Boggio, E., Ferrara, B., Trotta, F., Pizzimenti, S., Barrera, G., Boldorini, R., Bessone, F., Dianzani, U., Cavalli, R., & Dianzani, C.
(2020). Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models. Cancers, 12(1), 162.
https://doi.org/10.3390/cancers12010162